The agreement allows the biotech company to take full advantage of OmniComm’s First in Functionality, EDC solution, TrialMaster for up to 10 concurrent trials per year.
The biotech company will strategically utilize OmniComm’s electronic data capture (EDC) application to assist in managing their global clinical trials and clinical related data. The enterprise deal includes complete licensing, services and technical support for these 10 concurrent studies. The agreement also provides for an option to exceed 10 concurrent studies per year for a predetermined ‘per study’ price.